Drugs Approved by the FDA

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Morton Grove Pharmaceuticals
Approval Status: Approved July 1997
Treatment for: acne vulgaris

General Information

Morton Grove Pharmaceuticals' Clindamycin Phosphate Topical Solution USP 1%, an antibiotic for the treatment of acne vulgaris, has been approved by the FDA. According to the FDA approval letter, Morton Grove Pharmaceuticals' product was found to be equivalent to CLEOCIN Topical Solution 1%, marketed by Pharmacia & Upjohn Company.